PHVS: חובות מצטברים של החברה Pharvaris
Pharvaris N.V. (PHVS) delegates substance synthesis and clinical trials to external contractors, as it does not own its own manufacturing plants. The company's advantage lies in replacing injections with convenient tablets for the treatment of hereditary angioedema. This chart of share price quotes reflects the dynamics with debt at the level of 0.00. Currently, Pharvaris N.V. (PHVS) operates through the development of scientific projects without generating consistent profit.
פילוחים אנליטיים ודוחות נתונים של חברת Pharvaris (PHVS)
The price action of Pharvaris N.V. (PHVS) on this chart reflects the effectiveness of the issuer's financial stability management. Total liabilities capture the market value of aggregate borrowings, excluding reporting lags. This metric sums all short-term and long-term credit liabilities to assess default risk. Debt control is critical for maintaining the costly specialized logistics required for the delivery of orphan drugs. Optimizing this balance ensures uninterrupted patient supply and capital protection.